LISATA THERAPEUTICS INC已与Kuva Labs达成一项条款书,根据该协议,Kuva Labs将以每股4.00美元的价格,通过全现金要约收购的方式对LISATA THERAPEUTICS INC进行收购。
LISATA THERAPEUTICS INC已与Kuva Labs达成一项条款书,根据该协议,Kuva Labs将以每股4.00美元的价格,通过全现金要约收购的方式对LISATA THERAPEUTICS INC进行收购。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.